Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05273060
Other study ID # 21-004941
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 18, 2022
Est. completion date April 2025

Study information

Verified date June 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to gather information on the safety and effectiveness and compare nasal reconstruction standard planning versus 3D preoperative scanning/printing/planning.


Description:

Patients with nasal defects from cancer, trauma, prior surgery, or birth often require complex reconstruction. Current techniques involve hand sketched skin templates and/or hand carved cartilage grafts that are formed intraoperatively for nasal reconstruction. This process is time consuming, heavily depends on the surgeon's skill, cannot be standardized, and is difficult to visualize with patients preoperatively. To overcome these barriers and shift surgical paradigms, we will use a regenerative medicine approach to nasal reconstruction to create patient specific and individualized results. We will leverage regenerative medicine techniques of 3D surface mapping, 3D printing and modeling, and new tissue preparation techniques for skin template creation and sculpting of cartilage grafting. Clinically this will improve patient specific outcomes, increase reproducibility, reduce operative times, and allow for an individualized approach to nasal reconstruction. This will be achieved by (1) establishing ideal diced cartilage graft parameters in the laboratory setting for moldable cartilage graft formation. This knowledge will be applied to (2) create diced cartilage grafts for nasal dorsum and tip reconstruction from 3D printed nasal molds. For nasal skin reconstruction, (3) 3D facial scans of patients' preoperatively will be used to generate patient specific templates for skin reconstruction. Ultimately, (4) these regenerative medicine techniques of cartilage and skin reconstruction performed with 3D planning can be shared in an interactive format with patients preoperatively. This will allow patients to be involved in the surgical planning of their nasal reconstruction to increase their autonomy and the individualization of their surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date April 2025
Est. primary completion date April 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Males or female, age range is = 18 to = 100, based on historical surgical experience. - Patients undergoing nasal reconstruction. - Patients will be identified from the Facial Plastic Surgery clinic of the PI. Exclusion Criteria: - Patients < 18 are excluded because these cases are in combination with providers from PCH and patients have shared/limited postoperative follow up as a result.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
3D Nasal Reconstruction Planning
3D molds or models to use in the reconstruction of nasal cartilage

Locations

Country Name City State
United States Mayo Clinic Arizona Phoenix Arizona

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Viable nasal reconstruction Total number of subjects to have successful nasal reconstruction with transfer of viable tissue to reconstruct nasal defect 6 months
Secondary Nasal breathing Total number of subjects to have ability to move air through the nose for purposes of breathing 6 months
See also
  Status Clinical Trial Phase
Completed NCT06142981 - PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease N/A
Not yet recruiting NCT04011059 - Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix Phase 1/Phase 2
Completed NCT03912675 - Dermal Micrografts in Regenerative Surgery N/A
Recruiting NCT05043610 - MSCs for Prevention of MI-induced HF Phase 3
Not yet recruiting NCT04174898 - MSC Infusion for Anti-aging and Regenerative Therapy Phase 1